Literature DB >> 12962998

The tumor promoting effect of lime-piper betel quid in JB6 cells.

Ming-Hsun Lin1, Fen-Pi Chou, Hui-Pei Huang, Jeng-Dong Hsu, Ming-Yung Chou, Chau-Jong Wang.   

Abstract

Betel quid chewing is a general behavior in Taiwan, India, southeastern Asian and South Africa. In this study, microculture tetrazolium test (MTT) showed that the extract of lime-piper betel quid (LPB) (1.0-20 mg/ml) was toxic to JB6 cells. Cells exposed of LPB (0.1, 0.5, 1.0 mg/ml) for 7 days resulted in changes in cytomorphology with characteristics of carcinogenesis. With a long-term treatment (approximately 30 days) of low doses of LPB (1, 5, 10 microg/ml), the production of H2O2 and the activity of myeloperoxidase (MPO) and ornithine decarboxylase (ODC) were increased in JB6 cells. Cell cycle analysis showed a decrease in the G1 phase and an accumulation in the S phase 48 h after LPB treatment. When treating with 0.5 mg/ml LPB for 15 days as a promoter, type III foci were formed in the JB6 culture. These results demonstrated the tumor promotional effect of LPB in JB6 cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12962998     DOI: 10.1016/s0278-6915(03)00124-8

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  2 in total

1.  Consumption of betel quid contributes to sensorineural hearing impairment through arecoline-induced oxidative stress.

Authors:  Yen-Hui Chan; Tien-Chen Liu; Chun-Kang Liao; Yen-Fu Cheng; Ching-Hui Tsai; Ying-Chang Lu; Chin-Ju Hu; Hung-Ju Lin; Yungling Leo Lee; Chen-Chi Wu; Chuan-Jen Hsu
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

2.  Cytotoxic Effects of Betel Quid and Areca Nut Aqueous Extracts on Mouse Fibroblast, Human Mouth-Ordinary-Epithelium 1 and Human Oral Squamous Cell Carcinoma Cell Lines.

Authors:  Badr Abdullah Al-Tayar; Azlina Ahmad; Mohamad Ezany Yusoff; Siti Fadilah Abdullah; Noor Khairiena Mohamad; Siti Nurnasihah Md Hashim; Shosei Kishida; Michiko Kishida; Norifumi Nakamura; Toshiro Kibe; Masitah Hayati Harun
Journal:  Asian Pac J Cancer Prev       Date:  2020-04-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.